ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.717,42
0,19%
S&P 500
5.337,93
0,58%
Dow Jones
39.635,10
-0,09%
Euro vs US Dollar
1,08577
0,30%
Bitcoin
69.289,07
0,28%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. BetterLife Pharma Inc (QB) (BETRF)

  7. BetterLife Pharma Inc (QB) (BETRF) News

BETRF

BetterLife Pharma (QB) (BETRF)

BetterLife Pharma Inc (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:BETRF
DatumZeitQuelleÜberschriftSymbolFirma
14/05/202422h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
06/05/202415h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
05/03/202421h41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
02/01/202419h37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
29/12/202320h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
18/12/202318h13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
30/11/202319h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
29/09/202319h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
28/09/202315h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
05/09/202316h58Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
13/07/202317h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
28/06/202323h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
28/06/202323h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
28/06/202323h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
09/06/202322h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
06/06/202322h23Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)USOTC:BETRFBetterLife Pharma Inc (QB)
10/05/202315h00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
25/04/202319h35Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
08/03/202320h24Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
07/03/202322h31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
28/02/202315h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
18/01/202315h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
23/12/202215h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
08/12/202214h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
08/11/202223h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
27/09/202222h31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
29/06/202219h22Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
06/06/202220h35Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:BETRFBetterLife Pharma Inc (QB)
01/06/202212h00Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)USOTC:BETRFBetterLife Pharma Inc (QB)
04/03/202219h21Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
 Showing the most relevant articles for your search:USOTC:BETRF

Kürzlich von Ihnen besucht

BIT
P1VHM7
NLBNPIT1VHM7 20351221 4....
EU
BNPGH
BNP Paribas 7% Fixed to ...
NASDAQ
TKTX
Transkaryotic Therapies
GATE
NOOTUSDT
NOOT (Ordinals)
USOTC
VOHO
Volcan (CE)
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten